Development of hybrit mouse with humanized liver using superfreezing preserved human small hepatocytes.
Development of hybrit mouse with humanized liver using superfreezing preserved human small hepatocytes.
批准号:
20591615
负责人:
MIZUGUCHI Toru
金额:
$2.91万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010
中文摘要
点击翻译按钮获取中文摘要
英文摘要
It is very important to perform surgical operation to obtain cell donation for cell transplantation therapy. Conventional hepatectomy has been considered to be difficult to decrease high mobidity with mortlity. A saline-linked electiric cautery was very effective to achieve vessel sealing and decrease bleeding. In addition, recovery of postoperative Apo-B in this group was much faster than conventional hepatectomy (Hepatogastroenterology 2008 ; 55 : 2188-2192.). Gene transduction of Pdx-1 could transform small hepatocyte into insulin, glucagon, and somatostatine producing cells. Furthermore, small hepatocytes tend to be trans-differentiated into beta cells and mature hepatocytes tend to be trans-differentiated into alpha cells after transduction of Pdx-1 gene (J Hepatobiliary Pancreat Surg 2008 ; 15 : 403-409.). On the other hand, urinary trypsin inhibitor (UTI) is one of the proteins which the liver could produce by itself exclusively. The liver regeneration has been impaired in UTI deficient animals (Liver Int 2009 ; 29 : 979-987.). The gene expression could be depending on host conditions and human races. So, we compared gene expressions using micro DNA array analysis among Japanese patients and Finn patients (Genes Chromosomes Cancer 2010; 49: 28-39.). We proved all above research results and presented the data in both national and international congresses. We also discuss each other to promote further collaboration in future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Impaired liver regeneration with humoral and genetic disturbances in urinary trypsin inhibitor-deficient mice
尿胰蛋白酶抑制剂缺陷小鼠的体液和遗传紊乱导致肝再生受损
DOI:
--
发表时间:
2009
期刊:
Liver Int (in press)
影响因子:
--
作者:
[Mizuguchi T, Nagayama M, Meguro M, Shibata T, Kaji S, Nobuoka T, Kimura Y, Furuhata T, Hirata K]
通讯作者:
Hirata K
DOI:
10.1007/s10147-009-0888-1
发表时间:
2009-10-01
期刊:
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
影响因子:
3.3
作者:
[Meguro, Makoto, Furuhata, Tomohisa, Hirata, Koichi]
通讯作者:
Hirata, Koichi
DOI:
10.3727/096368908787236666
发表时间:
2008-10
期刊:
Cell Transplantation
影响因子:
3.3
作者:
[K. Sasaki;J. Kon;T. Mizuguchi;Qijie Chen;Hidekazu Ooe;H. Oshima;K. Hirata;T. Mitaka]
通讯作者:
K. Sasaki;J. Kon;T. Mizuguchi;Qijie Chen;Hidekazu Ooe;H. Oshima;K. Hirata;T. Mitaka
最善の肝切除術を目指した基本技術と新しい工夫
旨在实现最佳肝切除手术的基本技术和新理念
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[水口徹, 他]
通讯作者:
他
Hirata KCluster analysis of liver functional indicators and ALB-BTR classification to predict postoperative prognosis in 165 HCC patients.
Hirata KCluster 分析肝功能指标和 ALB-BTR 分级预测 165 例 HCC 患者术后预后。
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Mizuguchi T, Kawamoto K, Meguro M, Nakamura Y, Harada K, Nobuoka T]
通讯作者:
Nobuoka T
共 27 条
Development of novel cocktail solutions for cryo-preserving human small hepatocytes and generation of humanoid mouse liver
-
批准号:18591519
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.53万
-
财政年份:2006
-
负责人:MIZUGUCHI Toru
-
依托单位: